(Total Views: 182)
Posted On: 12/16/2017 9:53:13 AM
Post# of 212
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
$INSY Saturday morning. The week went well for INSY share holders. At $6.20/share, INSY still has a long climb back to its former teen dollar value BUT is making progress towards that end. Shareholders should be feeling a bit more confident that the share price will continue to increase.
INSYS Therapeutics appears to be managing these difficult times with a true professional approach. They are focusing on the strength of the company. Its R&D plus its current approved product lines are solid and have great value to the market. Presumably, they have planned for the next media assault of its former CEO, et al and will be prepared to support the stock and maintain its future value.
I remain very supportive of this stock and believe it to be a outstanding investment.
INSYS Therapeutics appears to be managing these difficult times with a true professional approach. They are focusing on the strength of the company. Its R&D plus its current approved product lines are solid and have great value to the market. Presumably, they have planned for the next media assault of its former CEO, et al and will be prepared to support the stock and maintain its future value.
I remain very supportive of this stock and believe it to be a outstanding investment.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)